https://orcid.org/0000-0002-2844-3597
References
- National Safety Council. Odds of dying: lifetime odds of death for selected causes, USA; 2017. Available from: https://injuryfacts.nsc.org/all-injuries/prevenTable-death-overview/odds-of-dying/
- National Center for Health Statistics, CDC Wonder. Drug overdose deaths. [cited 2019 Jun 27]. Available from: https://www.cdc.gov/drugoverdose/data/statedeaths.html
- National Center for Health Statistics, CDC Wonder. U.S. Opioid prescribing rate maps. [cited 2018 Oct 3]. Available from: https://www.cdc.gov/drugoverdose/maps/rxrate-maps.html
- National Center for Health Statistics, CDC Wonder. Synthetic opioid overdose data. [cited 2019 Apr 2]. Available from: https://www.cdc.gov/drugoverdose/data/fentanyl.html
- Mattick R, Breen C, Kimber J. et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Syst Rev – Interven. 2014; 2. Art. No.: CD002.
- Providers Clinical Support System. 8 hour online MAT waiver training. [cited 2020 Apr 15]. Available from: https://learning.pcssnow.org/p/matwaiverstudents
- Johnson M. Family medicine and the “new” opioid epidemic. J Am Board Family Med. 2020;33(1):1–4.
- McCance-Katz E, George P, Scott N, et al. Access to treatment for opioid use disorder: medical Student preparation. Am J Addict. 2017;26(4):316–318. .
- Howley L, Whelan A, Rasouli T, et al. Addressing the opioid epidemic: U.S. medical school curricular approaches. Analysis in brief. AAMC. 2018;18(1):1–3.
- McEwen S. NC medical schools step up efforts to address opioid epidemic: waiver training for students. N C Med J. 2019;80(3):191–192.
- Medication-Assisted Treatment - Practitioner and Program Data. Substance Abuse and Mental Health Services Administration (SAMHSA); 2019 Mar.
- Huhn A, Dunn K. Why aren’t physicians prescribing more buprenorphine? J Subst Abuse Treat. 2017;78:1–7.